Achieve Life Sciences Stock Beta
| ACHV Stock | USD 2.76 0.11 4.15% |
Achieve Life Sciences fundamentals help investors to digest information that contributes to Achieve Life's financial success or failures. It also enables traders to predict the movement of Achieve Stock. The fundamental analysis module provides a way to measure Achieve Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achieve Life stock.
Achieve |
Achieve Life Sciences Company Beta Analysis
Achieve Life's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Achieve Life Beta | 1.68 |
Most of Achieve Life's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achieve Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Achieve Life Sciences has a Beta of 1.677. This is 95.0% higher than that of the Biotechnology sector and 20.65% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Achieve Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achieve Life's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achieve Life could also be used in its relative valuation, which is a method of valuing Achieve Life by comparing valuation metrics of similar companies.Achieve Life is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Achieve Life will likely underperform.
Achieve Fundamentals
| Return On Equity | -4.1 | ||||
| Return On Asset | -0.84 | ||||
| Current Valuation | 71.35 M | ||||
| Shares Outstanding | 34.69 M | ||||
| Shares Owned By Insiders | 9.77 % | ||||
| Shares Owned By Institutions | 57.10 % | ||||
| Number Of Shares Shorted | 3.23 M | ||||
| Price To Earning | (0.03) X | ||||
| Price To Book | 4.58 X | ||||
| EBITDA | (38.84 M) | ||||
| Net Income | (39.83 M) | ||||
| Cash And Equivalents | 29.38 M | ||||
| Cash Per Share | 3.03 X | ||||
| Total Debt | 9.96 M | ||||
| Debt To Equity | 1.18 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 0.60 X | ||||
| Cash Flow From Operations | (29.77 M) | ||||
| Short Ratio | 14.61 X | ||||
| Earnings Per Share | (1.24) X | ||||
| Target Price | 16.44 | ||||
| Number Of Employees | 25 | ||||
| Beta | 1.68 | ||||
| Market Capitalization | 95.73 M | ||||
| Total Asset | 38.63 M | ||||
| Retained Earnings | (205.58 M) | ||||
| Working Capital | 29.79 M | ||||
| Current Asset | 22.54 M | ||||
| Current Liabilities | 9.1 M | ||||
| Net Asset | 38.63 M |
About Achieve Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achieve Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achieve Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achieve Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.